Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin”

1,123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,123 results

Early research (Phase 1)Looking for participantsNCT06815575
What this trial is testing

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Who this might be right for
Solid TumoursAdvanced Solid Tumours
Race Oncology Ltd 53
Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29
Testing effectiveness (Phase 2)Study completedNCT00052065
What this trial is testing

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Telik 28
Testing effectiveness (Phase 2)Study completedNCT00445406
What this trial is testing

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 43
Testing effectiveness (Phase 2)Ended earlyNCT01100944
What this trial is testing

PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Early research (Phase 1)Study completedNCT00846612
What this trial is testing

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Who this might be right for
Ovarian Cancer
NYU Langone Health 15
Testing effectiveness (Phase 2)Study completedNCT00001493
What this trial is testing

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 42
Not applicableLooking for participantsNCT05731258
What this trial is testing

Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

Who this might be right for
Breast CancerLiposomal DoxorubicinEfficacy+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 150
Early research (Phase 1)Ended earlyNCT02131506
What this trial is testing

Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerMalignant Neoplasm of Breast
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506
What this trial is testing

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast CancerDoxorubicin Induced Cardiomyopathy
Tanta University 36
Testing effectiveness (Phase 2)Ended earlyNCT00785798
What this trial is testing

Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

Who this might be right for
Relapsed LymphomasRefractory Lymphomas
Yale University 17
Testing effectiveness (Phase 2)UnknownNCT01872416
What this trial is testing

A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 30
Not applicableStudy completedNCT00135187
What this trial is testing

Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00665457
What this trial is testing

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Who this might be right for
Breast Cancer
University of Nebraska 3
Large-scale testing (Phase 3)Active Not RecruitingNCT02839707
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube High Grade Serous AdenocarcinomaOvarian High Grade Serous AdenocarcinomaOvarian Seromucinous Carcinoma+16 more
National Cancer Institute (NCI) 444
Early research (Phase 1)Study completedNCT01145430
What this trial is testing

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+7 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00544167
What this trial is testing

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 45
Large-scale testing (Phase 3)UnknownNCT00516425
What this trial is testing

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Charing Cross Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT00392340
What this trial is testing

Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 63
Load More Results